MedTrace Logo

Evaluation of RTVue XR With SSADA

NCT02535520 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2016-03-30

No results posted yet for this study

Summary

Optovue has implemented a motion contrast imaging software in RTVue XR, a split spectrum amplitude decorrelation algorithm (SSADA), for non-invasive imaging of ocular vasculature. Consented subjects will undergo a series of images of the back of the eye using an Optical Coherence Tomograpy (OCT) device, RTVue XR, in addition to the conventional images as part of clinical routine. SSADA images will be compared with conventional methods.

Conditions

  • Retina Vascular Pathology

Sponsors & Collaborators

  • Optovue

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2015-10-31
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02535520 on ClinicalTrials.gov